Increased PD-L1 expression in erlotinib-resistant NSCLC cells with <i>MET</i> gene amplification is reversed upon MET-TKI treatment

Christina Demuth(Aarhus University Hospital), Boe Sandahl Sørensen(Aarhus University Hospital)
Oncotarget
August 4, 2017
Cited by 35


Related Papers